We previously demonstrated that transient stromal cell-derived factor-1 alpha (SDF-1) improved cardiac function when delivered via cell therapy in ischemic cardiomyopathy at a time remote from acute ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback